The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Https://www.nasdaq.com/press-release/verona-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and
sound familiar?
mol
True regarding reporting every quarter with a wealth of info not available /required under aim
However VRP went down that route ..........
and I know how that went and it wasn't a success (jees they even rang the opening bell to rapturous applause)
delisted from aim c 2020
however their ADS still on nasdaq under vrna
https://www.nasdaq.com/market-activity/stocks/vrna
mol
They have released their own press release dated 18th Mar but i believe actually released to public today 19th
Gurugram, India – March 18, 2024 – Dr. Morepen, a trusted brand from Morepen
Laboratories (NSE: MOREPEN) known for household staples like Burnol and Lemolate,
announced a partnership with OptiBiotix Health plc (AIM: OPTI) to introduce a transformative
weight management solution to the Indian market.
"At Dr. Morepen, we've consistently empowered individuals to lead healthier lives," said
Varun Suri, CEO – Consumer Care at Morepen. "This collaboration with OptiBiotix’s
SlimeBiome (sic) allows us to take a significant step forward in addressing the alarming rise of
obesity in India.”
https://www.morepen.com/public/uploads/media/Morepen65f982b98b079.pdf
transformative and significant - their words
mol
Not sure that you have converted indian rupees or lakh to sterling correctly aquae
their financial statements look pretty impressive to me
and didn't note slimbiome on link provided
but if you have found your assertion re spending a lot of money promoting - i'll take that all day long
mind i also thought you would be one of the first to study links provided
best wishes
mol
Sold out? jees did they not order enough?
or is this just a prelim page on their website in advance of launch
https://muscletech.co.uk/products/nitro-tech-ripped
mol
Plenty of info available for anyone interested
https://www.morepen.com/investors
https://economictimes.indiatimes.com/morepen-laboratories-ltd/stocksupdate/companyid-11215.cms
and latest results (to Dec 23 and available as from 31 Jan 24 ) albeit not audited and whilst they will have an accounting team behind same - they will also have an abundance of transactions to record above our scant number
no reason why we cannot do the same once myers beds in - i'm not holding my breath though ( and it was once muted re a listing on nasdaq - can't remember who discussed it on here at time lol - I said at time not going to happen and continue to hold said view )
https://www.morepen.com/public/uploads/investor/Morepen65bb97fa1e35f.pdf
mol
4 hours ago
Stick with it...
I am 6 months in, haven't missed a day and most importantly...haven't done anything else. 20 plus years of on and off psoriasis. Covid and family losses collided and from 2020 I'd been in a flare which saw, small patches grow and join until my body was around 80/90% covered. Badly, deep deep flare. I am now down to 50% and that 50% is not deep, nowhere near as cracked,layered and sore. It will all be gone for good by my 12 month AxisBiotix anniversary!!🎉
Date of experience: 12 March 2024
8 hours ago
Impressed!!
Stick with it! I really, really like this product but it does take time to kick in. I am now 3 months in and have just started to see a positive effect. I’ve suffered with psoriasis for about 10 years, predominantly scalp psoriasis and plaques across my stomach and back. I’ve tried lots of treatments under a dermatologist, from steroid creams to immunosuppressants drugs. Whilst effective, I found them quite harsh and not really long term solutions.
Since starting AxisBiotix, the plaques on my body have completely cleared and I am now able to manage my scalp psoriasis with a topical shampoo, rather than a daily steroidal ointment soak.
I am interested to see how the next 6 months go.
mol
Professor McBain at this conference in June
Presentation Outline
The potential role of the microbiome in overall skin health and in skin ageing is being increasingly recognised. Microbiome research is often complicated by considerations of correlation versus causation, and this applies to studies of human ageing as much as anywhere else. However, ageing-related changes in microbiome composition have been reported and ongoing research should focus on potential mechanisms, which may involve direct interaction with the skin and the host immune system, and the production of microbial metabolites. Microbiome-based interventions, such as probiotics, prebiotics, and postbiotics, have emerged as potential therapeutic strategies to modulate the skin microbiome and promote healthy skin ageing. This presentation will explore the current understanding of the skin microbiome's role in ageing and discuss potential microbiome-based interventions for promoting healthy skin ageing.
https://summit-events.com/anti-ageing/speaker-programme
mol
Or not perhaps
https://www.dermatonics.co.uk/collections/shop
heel balm, as anyone here, should know just one of a number of products making up the last reported turnover of £1.86m
which i found underwhelming given the price paid
and i'm also not overly impressed with umesh modi website - nor their turnover - at least what appears to be their reported turnover - as one who has tried over a number of years to gain an insight into privately owned companies in India - not an easy exercise and also, whilst an extemely large potential market, not one that readily avails itself to outside companies.
but after all the back slapping and self promotion amongst a number of posters here
nobody has actually then put a figure on the increased turnover expected in say year ended 31 Jun 2025 - or am i wrong - but even more importantly profit before tax to bottom line from this
20 February 2024 - SkinBioTherapeutics plc, (AIM: SBTX, or the "Company"), the life science business focused on skin health, announces that its newly acquired company Dermatonics is set to launch Pheet and Dermatonics Once Heel Balm in Asia, Middle East and Africa (AMEA) in partnership with the Umesh Modi Group (the Group) following the signing of a manufacturing and distribution agreement on 30 June 2023.
Pheet and Dermatonics products are used for the treatment of dry foot skin and are sold under the Dermatonics brand in the rest of the world. The Once Heel Balm product will be manufactured by the Umesh Modi Group and sold directly by its sales team of over 1,200 people across six countries including India, Bangladesh Sri Lanka and Nigeria. The total addressable market in these regions for dermatology and diabetes management is in excess of £5bn. This collaboration is currently at an early stage, therefore, the management does not expect any changes to current market expectations at this stage.
mad after all
mol
Https://soundcloud.com/optibiotix-investor/february-29th-2024
Something to listen to over the weekend
mol
Evening grizzlyb
just popped in this evening, after a number of years, and whilst not surprised at all re the suspension i sincerely hope you haven't lost any money here
i remember well our discussions of old
bw for the future
and anyone else still here after all these years
jees at one point exosomes were only the icing on the cake
mol
I've actually more than doubled my holding this afternoon
mind
I've been mad for ******* years, absolutely years
Been over the edge for yonks
Been working me buns off for bands
I've always been mad, I know I've been mad
Like the most of us, very hard to explain why you're mad
Even if you're not mad
mol
Our FD (albeit part-time) was only appointed on 4th Dec 2023
https://www.optibiotix-ir.com/content/news/archive/2023/041223
but now also noted on website
https://optibiotix.com/corporate/
albeit i accept an update to the revenue potential from May 2023 slides , prior to his appointment, would be more than useful - but give him a bit more time!
slides here - which at time of release i noted underwhelming for 2024 and even 2025
https://www.walbrookpr.com/docs/librariesprovider48/default-document-library/investors/optibiotix---investor-presentation-may-2023.pdf
just reminding the bb re the only figures we have to date - again as far as i'm aware
mol
Evening all
a positive step forward indeed and further improvement on the last rns only c 3 weeks ago
https://www.optibiotix-ir.com/content/news/archive/2024/300124
a reminder from May 2023 presentation and deals signed - albeit nothing since on dsm-firmenich % royalty, as far as i'm aware, unlike US partner
SweetBiotix: A portfolio of sweet low-calorie fibres created by combining prebiotic functional fibres and modified mogrosides or steviol glycosides in a single enzymatic step
Commercial Status:
i. Manufacturing agreement signed with US partner September 2020 for mogroside product
i. Scale up optimization completed/optimised products received December 2022 as liquid, freeze dried in May
ii. Partner taste testing confirms product acceptability. Analytical testing and structural analysis underway
iii. Structural analysis underway to determine novelty and the regulatory pathway
iv. Independent peer reviewed publication confirms sweetness and prebiotic functionality highlighting health benefits – start of marketing
v. Six figure annual milestone paid during scale up plus six figure launch milestone
vi. Royalties 5% plus a further 5% on 11 named companies( Kelloggs, Nestle, Coca Cola ,Firmenich, Tereos, Cargill, Arla ,Tate and Lyle, Agropur, Givaudan, Tata)
ii. Agreement signed with Firmenich July 2022 for stevia glycoside product
i. Manufacturing agreement signed and project progressing rapidly
ii. Manufacturing scale up underway, product produced and tested, process optimization underway to enhance yield
iii. Payments: Six figure payment per market approval (USA/Europe/Asia) - potential H2 2023/H1 2024
iv. One off six figure milestone when reaching $5m and $12m sales plus royalties on all sales
Next Steps:
Structural and functional analysis, regulatory approvals, partner application development and launch discussions
which more or less is noted in
https://www.optibiotix-ir.com/content/news/archive/2023/190723
mol
I know what due diligence means
Please do not try to obfuscate the issue here by linking to Opti and their releases and skin being taken by surprise
Obviously there is a fan club here who continue to think that our current office holders know the best way forward
They have little skin in the game whilst drawing over the top salaries
Just my opinion but they should at least reduce their salaries by at least 50% or resign
mol